Cite
HARVARD Citation
Nabholtz, J. et al. (n.d.). Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer. International journal of cancer. 138 (9), pp. 2274-2280. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nabholtz, J. et al. (n.d.). Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer. International journal of cancer. 138 (9), pp. 2274-2280. [Online].